Cytosorbents
0 sources
Financials
0001144204-19-012774Cytosorbents
Summary
Cytosorbents is a business[1].
Key Facts
- Cytosorbents is in the country of US[2].
- Cytosorbents's instance of is recorded as business[3].
- Cytosorbents's instance of is recorded as public company[4].
- Cytosorbents's headquarters location is recorded as Monmouth Junction[5].
- Cytosorbents's stock exchange is recorded as Nasdaq[6].
- Cytosorbents's industry is recorded as Critical care[7].
- Cytosorbents's official website is recorded as https://cytosorbents.com/[8].
- Cytosorbents's legal form is recorded as XTIQ[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300VI8WO8GK5QK793[10]
-
Registered legal name: CytoSorbents Corporation[11]
-
Legal jurisdiction: US-DE[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): XTIQ[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
LEI first registered: 2014-11-26[17]
-
LEI last updated: 2023-08-04[18]
-
LEI next renewal: 2016-12-17[19]
-
Managing LOU: 5493001KJTIIGC8Y1R12[20]
-
Registration authority: RA999999[21]
-
Conformity flag: NON_CONFORMING[22]
Body
Operations
Cytosorbents's headquarters location is recorded as Monmouth Junction[5].
Industry
Cytosorbents's industry is recorded as Critical care[7].
Ownership
Cytosorbents's stock exchange is recorded as Nasdaq[6].